Yeast Surface Display Platform

• Yeast Surface Display Service
• TCRm Antibody Yeast Display Development Service
• Enzyme Protein Evolution Yeast Display Service

Phage Display Platform

• scFv Antibody Development Services
• Nanobody Development Services

Antibody Drugability Assessment

• TCR-T Lead Sequence Development Service
• Immune CAR Cell Preparation Technology Service
• Antibody Coupled Drug Discovery Service
• Antibody Affinity Maturation Service
• Antibody Humanization Services
• Bispecific Antibody Development Services
• Antibody Protein Sequencing Service
• Antibody Affinity Determination Service

Aptamer Discovery Service

• Aptamer-Drug Conjugate (ApDC) Development Services
• Nuclide Nucleic Acid Aptamer Screening Service
• Nucleic Acid Aptamer Synthesis Service
• Nucleic Acid Aptamer Modification Service
• Nucleic Acid Aptamer Library Construction Service
• Bispecific Aptamer Development Service
• Protein Nucleic Acid Aptamer Screening Service
• Metal Ion Nucleic Acid Aptamer Screening Service
• Small Molecule Nucleic Acid Aptamer Screening Service
• Cell Nucleic Acid Aptamer Screening Service

Active Peptide Discovery Technology Service

• Peptide Affinity Maturation Services
• Peptide-Drug Conjugate (PDC) Development Services
• Stapled Peptide Development Services
• Targeted Peptide Library Screening Service
• Targeted Peptide Library Construction Service

Animal Immunization Technology Services

• mRNA Antibody Production Services
• mRNA Immunogen Production Service
• DNA Immune Antibody Preparation Service

Yeast Hybrid Technology Platform

• Yeast Two-hybrid (Nuclear System) Service
• Yeast Two-hybrid (Membrane System) Service
• Yeast cDNA Library Construction Technology Service
• Yeast One Hybrid Service

Recombinant Antibody Expression Services

• Recombinant Chimeric Antibodies Customized Services
• Recombinant IgG Customization Services
• Recombinant Fragment Antibody Customization Service

Nano-body Support Articles

• Structural Basis for Selectivity and Antagonism in GPCR-Nanobodies
• Novel Peptide-Drug Conjugate (PDC) Shows Efficacy in Hepatocellular Carcinoma Models
• Nanobody Expression in Insect Cells
• Nanobody Mammalian Cell Expression
• Single-chain Antibody Library Construction Technology Introduction
• Prokaryotic Expression of Nanobodies
• Cell Line Immunogen of Nanobody
• Construction of Single Chain Antibody Library
• Nano-antibody/Single Domain Antibody Library Construction Service
• Customized Nano-antibody Immunogen3

Special topic on antibody modification

• Bispecific Antibodies (bsAbs): Mechanisms of Action Explained
• Applications of bispecific antibodies in cancer therapy
• Beyond PD-1 Blockade: How BiCE Bridges T Cells and cDC1s to Unlock Cold Tumors
• From Purity to Functionality: A Comprehensive Guide to Recombinant Antibody Quality Control Standards
• How much do you know about the molecular design and mechanism of action of ADC drugs?
• The ADC linker serves as a crucial "bridge" component.
• ADCs are becoming increasingly mature in the field of tumor therapy.
• Cracking the Immune System’s “Source Code”: Why Is B-Cell Technology the Ultimate Path to Antibody Discovery?
• Five Golden Areas of Single B Cell Technology
• How much do you know about ADC drug development?

Yeast Display Technology Special Topic

• How Are Antibody Drugs Produced? A Deep Dive into Mammalian Cell Culture and Purification Processes
• Expression of Recombinant Antibodies in Mammalian Cells: Core Technologies – Comprehensive Analysis of Host Selection and Purification Strategies
• Bacteriophages, yeast, mRNA display: Who is the champion of the display technology?
• Breakthrough: Ultra-High Sensitivity Detection of Legionella Using an Aptamer-Based Electrochemical Sensor
• Construction of yeast hybrid library: Gateway technology
• Eukaryotic System-Based Targeted Drug Discovery Platform: Yeast Display Technology
• Common Problems and Solutions for Yeast Two-hybrid Experiments
• Yeast Two-hybrid Technique Related Issues
• Common Problems and Solutions of Yeast Display Technology
• Overview of Yeast Two Hybrid System Principle and Application

Antibody Detection Service Topic

• Stop Sticking with Hybridoma! A Primer on the Three Generations of Antibody Discovery Technology
• Rationale and Significance of Bispecific Antibody Development
• Protein Not Expressing? You Might Have Chosen the Wrong Tag!
• What to Do After Protein Purification? These Four Validation Methods You Must Know!
• Yeast Two-Hybrid Technology Reveals a Novel Mechanism of Wheat Disease Resistance: How TaPIR1 "Hijacks" TaHRP1 to Suppress Chloroplast Function?
• Yeast Hybrid Library Construction: Smart Technology
• New Molecular Interaction Technology: How Much Do You Know About Yeast Hybridization Technology?
• Antibody Affinity Testing(SPR)
• Hybridoma Gene Sequencing Process
• Antibody Affinity Detection (BLI)

Special Topic on Phage Display Technology

• Frontiers in Targeted Drug Development: Comparison and Application of Various Peptide Screening Methods
• Application of phage display (Part 2)
• Application of phage display (Part 1)
• Phage Display
• Technical Article: Detailed Guide to Phage Screening
• Frontiers in Targeted Drug Development: Comparison and Application of Multiple Peptide Screening Methods
• Revolutionary Advances in Single-Domain Antibody Development and Applications
• New Method for Discovering Targeted Drugs: Screening of Peptide Libraries Based on Phage Display Technology
• How much do you know about IgG, Fab, scFv, and VHH?
• Novel Targeted Tumor Therapeutics: Efficacy of a Peptide-Drug Conjugate (PDC) in a Hepatocellular Carcinoma Model

CAR-T Molecule Discovery Topic

• CD7-targeted Antibody-Drug Conjugates: A New Hope for T-Cell Acute Lymphoblastic Leukemia
• Discovery of targeted nucleic acid small molecules: Cell-SELEX technology
• A Promising Novel Cancer Therapeutic Strategy: Aptamer-Drug Conjugates (ApDCs)
• A Novel Therapeutic Approach for Multiple Myeloma: Development of a CD38 and CD47 Bispecific Bipartopic Antibody
• A Novel Therapeutic Approach - CAR-M
• Application And Prospects of CAR-T Technology in Tumor Immunotherapy
• CAR-T Discovery Service

Molecular Biology Service Topics

• In Vivo Screening Services – Animal Models
• The Promise of Small Nucleic Acid Therapeutics: From Bench to Clinic as Next-Generation Medicines
• Issues Related to Aptamer Library Screening
• Introduction to Nucleic Acid Aptamer Library Screening Technology
• Overview of Aptamer Synthesis Technology
• Screening and optimization of nucleic acid aptamers
• Screening and Application of Peptide Aptamers
• Main Research Directions Progress and Challenges of Nucleic Acid Aptamer Screening Technology
• Research Progress of Protein Nucleic Acid Aptamer Screening
• Research Progress of Aptamer Screening-of Small Molecule Targets

Biosimilar Antibody Reagent

Nanobody Related Reagent